<VariationArchive VariationID="1338644" VariationName="NM_001276270.2(MBD4):c.939dup (p.Glu314fs)" VariationType="Duplication" Accession="VCV001338644" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2022-01-29" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1329651" VariationID="1338644">
      <GeneList>
        <Gene Symbol="MBD4" FullName="methyl-CpG binding domain 4, DNA glycosylase" GeneID="8930" HGNC_ID="HGNC:6919" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="129430947" stop="129439948" display_start="129430947" display_stop="129439948" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="129149792" stop="129158851" display_start="129149792" display_stop="129158851" Strand="-" />
          </Location>
          <OMIM>603574</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001276270.2(MBD4):c.939dup (p.Glu314fs)</Name>
      <CanonicalSPDI>NC_000003.12:129436704:TTTTTTTTTT:TTTTTTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="129436704" stop="129436705" display_start="129436704" display_stop="129436705" variantLength="1" positionVCF="129436704" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="129155547" stop="129155548" display_start="129155547" display_stop="129155548" variantLength="1" positionVCF="129155547" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>E314fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.129155557dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.129155557dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.129436714dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.129436714dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023392.1" sequenceAccession="NG_023392" sequenceVersion="1" change="g.1590dup">
            <Expression>NG_023392.1:g.1590dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033106.1" sequenceAccession="NG_033106" sequenceVersion="1" change="g.8475dup">
            <Expression>NG_033106.1:g.8475dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276270.2" sequenceAccession="NM_001276270" sequenceVersion="2" change="c.939dup" MANESelect="true">
            <Expression>NM_001276270.2:c.939dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263199.1" sequenceAccession="NP_001263199" sequenceVersion="1" change="p.Glu314fs">
            <Expression>NP_001263199.1:p.Glu314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276271.2" sequenceAccession="NM_001276271" sequenceVersion="2" change="c.939dup">
            <Expression>NM_001276271.2:c.939dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263200.1" sequenceAccession="NP_001263200" sequenceVersion="1" change="p.Glu314fs">
            <Expression>NP_001263200.1:p.Glu314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276272.2" sequenceAccession="NM_001276272" sequenceVersion="2" change="c.939dup">
            <Expression>NM_001276272.2:c.939dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263201.1" sequenceAccession="NP_001263201" sequenceVersion="1" change="p.Glu314fs">
            <Expression>NP_001263201.1:p.Glu314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003925.3" sequenceAccession="NM_003925" sequenceVersion="3" change="c.939dup">
            <Expression>NM_003925.3:c.939dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003916.1" sequenceAccession="NP_003916" sequenceVersion="1" change="p.Glu314fs">
            <Expression>NP_003916.1:p.Glu314fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276273.2" sequenceAccession="NM_001276273" sequenceVersion="2" change="c.247+1103dup">
            <Expression>NM_001276273.2:c.247+1103dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003925.2" sequenceAccession="NM_003925" sequenceVersion="2" change="c.939dupA">
            <Expression>NM_003925.2:c.939dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603574.0003" DB="OMIM" />
        <XRef Type="rs" ID="558765093" DB="dbSNP" />
      </XRefList>
      <GlobalMinorAlleleFrequency Value="0.00300" Source="1000 Genomes Project" MinorAllele="TTTTTTTTTTT" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001276270.2(MBD4):c.939dup (p.Glu314fs) AND not specified" Accession="RCV001818015" Version="4">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-21" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001276270.2(MBD4):c.939dup (p.Glu314fs) AND Tumor predisposition syndrome 2" Accession="RCV002274219" Version="2">
        <ClassifiedConditionList TraitSetID="79260">
          <ClassifiedCondition DB="MedGen" ID="C5774186">Tumor predisposition syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001276270.2(MBD4):c.939dup (p.Glu314fs) AND not provided" Accession="RCV002545186" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-25" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2022-01-29" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">30049810</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31322271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35460607</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="79260" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65696" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MBD4-ASSOCIATED NEOPLASIA SYNDROME</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumor predisposition syndrome 2</ElementValue>
                <XRef ID="MONDO:0859267" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS2</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MANS</ElementValue>
                <XRef Type="MIM" ID="619975" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774186" DB="MedGen" />
              <XRef ID="MONDO:0859267" DB="MONDO" />
              <XRef Type="MIM" ID="619975" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4052035" SubmissionDate="2022-01-25" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_003925.2(MBD4):c.939dup|not specified" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002065836" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>DNA sequence analysis of the MBD4 gene demonstrated a single base pair duplication in exon 3, c.939dup. This duplication is predicted to result in a frameshift and a premature stop codon, p.Glu314Argfs*13. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated MBD4 protein with potentially abnormal function. This sequence change has been described in gnomAD with a frequency of 0.1% in the South Asian sub-population (dbSNP rs558765093). This sequence change has been reported in a case with early onset AML but this has not been proven conclusively (PMID: 30049810). The functional significance of this sequence change is not known at present</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003925.2:c.939dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not specified</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987855</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5007155" SubmissionDate="2022-08-08" DateLastUpdated="2022-08-15" DateCreated="2022-08-15">
        <ClinVarSubmissionID localKey="603574.0003_TUMOR PREDISPOSITION SYNDROME 2" title="MBD4, 1-BP DUP, NT939 (rs558765093)_TUMOR PREDISPOSITION SYNDROME 2" />
        <ClinVarAccession Accession="SCV002559252" DateUpdated="2022-08-15" DateCreated="2022-08-15" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Note: The protein change resulting from the c.939dup mutation differed in the reports of Sanders et al. (2018) and Palles et al. (2022): Val314ArgfsTer13, NM_003925 and Glu314ArgfsTer13, NM_003925.2, respectively.</Attribute>
              <Citation>
                <ID Source="PubMed">30049810</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">35460607</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp duplication (c.939dup, NM_003925) in the MBD4 gene, resulting in a frameshift and premature termination (Val314ArgfsTer13), that was found in compound heterozygous state in 2 sisters with tumor predisposition syndrome-2 (TPDS2; 619975) by Sanders et al. (2018), see 603574.0002.</Attribute>
              <Citation>
                <ID Source="PubMed">30049810</ID>
              </Citation>
              <XRef DB="OMIM" ID="619975" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs (family CRDFF-336) and an unrelated man (family CRDFF-292) with TPDS2, Palles et al. (2022) identified a homozygous germline c.939dup mutation (NM_003925.2) in the MBD4 gene, resulting in a frameshift (Glu314ArgfsTer13). The mutation, which was found by whole-exome, whole-genome, or targeted sequencing and confirmed by Sanger sequencing, was present only in the heterozygous state in the gnomAD database (6.53 x 10(-4)). Another woman with the disorder (family DB1) was found to be compound heterozygous for c.939dup and a c.1688T-A transversion, resulting in a leu563-to-ter (L563X; 603574.0005) substitution. The patients had onset of various types of tumors as young adults, including multiple colorectal polyps and adenomas, ovarian granulosa cell tumor, uveal melanoma, meningiomas, and schwannomas. The patient from family CRDFF-292 had a deceased brother with colorectal carcinoma and leukemia, but DNA from this individual was not available. The patient from family DB1 had a deceased affected sister with colorectal adenomas, uveal melanomas, and AML; DNA was not available from this individual. The parents of the sibs in family CRDFF-336 each carried the mutation in heterozygosity, consistent with autosomal recessive inheritance.</Attribute>
              <Citation>
                <ID Source="PubMed">35460607</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD4" />
          </GeneList>
          <Name>MBD4, 1-BP DUP, NT939 (rs558765093)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT939 (rs558765093)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603574.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUMOR PREDISPOSITION SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5964515" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="2969573|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003274351" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30049810</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35460607</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30049810</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu314Argfs*13) in the MBD4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MBD4 are known to be pathogenic (PMID: 30049810, 35460607). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with acute myeloid leukemia (PMID: 30049810). ClinVar contains an entry for this variant (Variation ID: 1338644). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.129155547_129155548insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9873582" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_003925_2_MBD4_c_939dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005086189" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30049810</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31322271</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35460607</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with tumour predisposition syndrome 2 (MIM#619975). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v3 - 45 heterozygotes, 0 homozygotes). However, population frequency may be overestimated or underestimated due to the location of this variant in a low complexity region. (SP) 0703 - Other NMD-predicted variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. PMID: 31322271 identified a germline heterozygous variant in MDB4, c.217C&gt;T (p.Gln73*), and loss of heterozygosity in tumour tissue in a female with early-onset colonic polyposis and colorectal cancer. PMID: 35460607 identified a homozygous MDB4 variant, c.612_615del (p.Ser205Thrfs*9), in a male with AML and polyposis. (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. PMID 35460607 identified this variant as homozygous or compound heterozygous in four individuals from three families affected by colonic polypsis and AML or uveal melanoma. PMID: 30049810 report this variant as compound heterozygous in two siblings with early-onset AML. Two other unrelated individuals with this variant in trans with another pathogenic/likely pathogenic MBD4 variant diagnosed with polyposis and AML have also been identified (Invitae, Clinvar). (SP) 0906 - Segregation evidence for this variant is inconclusive due to lack of sufficient number of affected individuals and/or genotyping in the published families (PMID: 35460607; PMID: 30049810). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1101 - Very strong and specific phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MBD4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_21370</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003925.2:c.939dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619975" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9873582" TraitType="Disease" MappingType="XRef" MappingValue="619975" MappingRef="OMIM">
        <MedGen CUI="C5774186" Name="Tumor predisposition syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5964515" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4052035" TraitType="Disease" MappingType="Name" MappingValue="not specified" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5007155" TraitType="Disease" MappingType="Name" MappingValue="TUMOR PREDISPOSITION SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C5774186" Name="Tumor predisposition syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

